单次卵巢刺激周期实现两次活产:再论「一次完成」策略
该回顾性队列研究纳入2014年1月1日至2022年12月31日期间首次接受体外受精(IVF)刺激/胚胎创建周期的16474例患者,分析单次刺激周期后自体胚胎移植的活产情况。结果显示8223例(49.9%)获得≥1次活产,1857例(11.3%)获得≥2次活产;纳入剩余冷冻高质量胚胎的额外活产估算后,9599例(58.3%;95%CI 57.6%-59.1%)可获得≥1次活产,4511例(27.3%;95%CI 26.8%-28.0%)可获得≥2次活产。年龄<35岁和获卵数增加与获得≥2次活产的 odds 升高相关,使用胚胎植入前非整倍体遗传学检测(PGT-A)者获得≥2次活产的 odds 较低。
要点
- 单次IVF刺激周期后,11.3%患者实际获得≥2次活产,估算可达27.3%。
- 获卵数增加和年龄<35岁与获得≥2次活产的 odds 升高相关。
- 使用PGT-A者获得≥2次活产的 odds 较低。
核心结论
- 在当前IVF实践下,超过四分之一患者可通过单次IVF刺激周期获得≥2次活产来完成家庭生育。
- 获卵数增加和年龄<35岁可提高实现该结果的 odds。
- 临床医生可将这些数值作为咨询工具,指导共享决策以避免额外的刺激周期。
研究设计与样本
- 回顾性队列研究,在大学附属不孕症诊所进行。
- 纳入2014年1月1日至2022年12月31日期间首次接受IVF周期的患者,共16474例,研究期间共进行20710次移植。
- 暴露为索引取卵周期及后续自体胚胎移植周期。
- 采用单变量和多变量逻辑回归模型评估已知生育因素与结局的关联。
主要发现
- 8223例患者(49.9%)获得≥1次活产,1857例患者(11.3%)获得≥2次活产。
- 6662例患者(40.4%)共有24067枚剩余冷冻高质量胚胎。
- 纳入剩余冷冻胚胎的额外活产估算后,9599例患者(58.3%;95%CI 57.6%-59.1%)可获得≥1次活产,4511例患者(27.3%;95%CI 26.8%-28.0%)可获得≥2次活产。
- 获得≥2次活产的患者比例随获卵数增加而逐步升高,随年龄增长而降低。
- 5105例患者(31.0%)使用了PGT-A,使用者获得≥2次活产的 odds 较低。
临床怎么用
- 作者认为,临床医生可将这些数值作为咨询工具,指导共享决策以避免额外的刺激周期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the proportion of patients who would achieve ≥2 live births after a single in vitro fertilization (IVF) stimulation/embryo creation cycle. DESIGN: Retrospective cohort study at a university-affiliated infertility practice. SUBJECTS: Patients undergoing their first IVF cycle between January 1, 2014, and December 31, 2022. EXPOSURE: Index oocyte retrieval cycle and subsequent autologous embryo transfer cycles. MAIN OUTCOME MEASURES: Live births after autologous embryo transfer cycles from the index oocyte retrieval were analyzed, with additional live birth potential estimates extrapolated using age and oocyte number for those who had remaining frozen high-quality embryos. Univariable and multivariable logistic regression models were used to evaluate the association of known fertility factors with the outcome. RESULTS: A total of 16,474 patients were included who underwent 20,710 total transfers during the study period. A total of 8,223 patients (49.9%) achieved ≥1 live birth, and 1,857 patients (11.3%) achieved ≥2 live births. Of note, 6,662 patients (40.4%) had a total of 24,067 remaining frozen high-quality embryos. Including estimates of additional live births resulting from use of remaining frozen embryos, 9,599 patients (58.3%; 95% confidence interval, 57.6%-59.1%) would achieve ≥1 live birth and 4,511 patients (27.3%; 95% confidence interval, 26.8%-28.0%) would achieve ≥2 live births. The proportion of patients achieving ≥2 live births progressively increased across groups of increasing oocyte yield and decreased with advancing age. Predictors of the odds of achieving ≥2 live births included age and number of oocytes retrieved. A total of 5,105 patients (31.0%) used preimplantation genetic testing for aneuploidy. Those who used preimplantation genetic testing for aneuploidy had a lower odds of achieving ≥2 live births. CONCLUSION: With current IVF practices, over one fourth of patients could complete their families by achieving ≥2 live births from a single IVF stimulation cycle. The increasing number of oocytes retrieved and age of <35 years increased the odds of achieving this result. Providers can use these values as a counseling tool to guide shared decision-making to avoid additional stimulation cycles.
引用
- Huttler A, Duvall D, Sakkas D, et al. Achieving two live births from one ovarian stimulation cycle: the one-and-done approach revisited. Fertil Steril. 2025. PMID: 40712966. doi:10.1016/j.fertnstert.2025.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。